Physician profile
Claudio P Bernaschina Bobadilla
NPI 1922197011
$131,687.42
in general payments reported to CMS, 2019-2025
22 companies · $31K in 2025
The $31K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,172 · 2020: $150 · 2021: $21K · 2022: $17K · 2023: $28K · 2024: $33K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $67K · Consulting Fee: $18K · Food and Beverage: $3,543 · Travel and Lodging: $3,136 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $67,275.00 |
| Consulting Fee | $17,990.00 |
| Food and Beverage | $3,543.43 |
| Travel and Lodging | $3,135.79 |
| Education | $153.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $65,069.58 | 2021-2025 | Trelstar |
| Teleflex LLC | $51,950.14 | 2019-2024 | Urolift |
| Abbvie INC. | $6,250.25 | 2025 | |
| Boston Scientific Corporation | $2,561.85 | 2019-2025 | Ams 700 Cxr Rte Kit, Ams 700, Spaceoar Vue System - 10ml |
| Janssen Pharmaceuticals, INC | $1,540.94 | 2019-2025 | Erleada, Talvey, Darzalex |
| Neotract INC. | $1,436.45 | 2019-2020 | |
| Medtronic, INC. | $603.67 | 2019-2024 | Signia, Interstim |
| E.R. Squibb & Sons, L.L.C. | $358.19 | 2023-2024 | Opdivo, Camzyos |
| Becton, Dickinson and Company | $336.48 | 2023-2025 | Powerport M.R.I. Implantable Port, Powerpicc, Aptra |
| Janssen Biotech, INC. | $325.04 | 2019-2024 | Erleada |
| Pfizer INC. | $249.45 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $242.79 | 2024-2025 | Keytruda |
| Astellas Pharma US INC | $198.60 | 2023 | Xtandi |
| Pbg Puerto Rico LLC | $177.46 | 2021-2025 | |
| Allergan, INC. | $104.79 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $92.00 | 2023 | Pylarify |
| Smith+Nephew, INC. | $54.71 | 2023 | Renasys Touch, Allevyn Life L 15.4x15.4 Ctn10, Acticoat 4" X 4" |
| Baxter Healthcare | $54.50 | 2024 | Floseal |
| Tolmar, INC. | $36.38 | 2023 | |
| Ferring Pharmaceuticals INC. | $22.30 | 2019 | |
| Novo Nordisk INC | $19.14 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudio Bernaschina Bobadilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.